Entacapone

Entacapone

SCHEMBL3395296

CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1.CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

COMT

The experimentally established mechanism targets of Entacapone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
COMT known ✓ P21964 5/20 1.00
FTO Q9C0B1 8/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
ABCC3 O15438 1/20 1.00
ABCC4 O15439 1/20 1.00
ABCB11 O95342 1/20 1.00
LMNA P02545 1/20 1.00
CYP2C9 P11712 1/20 1.00
GPR35 Q9HC97 1/20 1.00
EGFR P00533 1/20 0.62
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
HPGD P15428 1/20 0.60
RECQL P46063 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Entacapone SCHEMBL34505 1.00 FTO (1.00) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL29356206 1.00 FTO (1.00) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL34504 1.00 FTO (1.00) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL3934631 1.00 FTO (1.00) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL29406523 1.00 FTO (1.00) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL27766815 0.99 FTO (0.98) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL4940150 0.98 FTO (0.96) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL4940155 0.98 FTO (0.96) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL26128138 0.97 FTO (0.94) FTOCOMTMEN1KMT2AABCC3
Entacapone SCHEMBL3972337 0.96 FTO (0.92) FTOCOMTMEN1KMT2AABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183594-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) 2023-09-28 WO disclosed
EP-3191105-A1 SULFATE SALT SOLUTION LAXATIVE COMPOSITIONS AND METHODS OF USE THEREOF Braintree Laboratories, Inc. (US) 2017-07-19 EP disclosed
WO-2016040733-A1 SULFATE SALT SOLUTION LAXATIVE COMPOSITIONS AND METHODS OF USE THEREOF BRAINTREE LABORATORIES, INC. (US) 2016-03-17 WO disclosed
EP-2156839-A1 Method of treating movement disorders using barbituric acid derivatives Taro Pharmaceutical Industries Ltd. (IL) 2010-02-24 EP disclosed